RenovoRx Inc. (RNXT)
NASDAQ · Healthcare
RenovoRx Inc. EPS 2024–2025
RenovoRx Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- RenovoRx Inc. eps for the quarter ending March 31, 2026 was $0.09, a 12.50% increase year-over-year.
- RenovoRx Inc. annual eps for 2025 was $0.32, a 20.00% decrease from 2024.
- RenovoRx Inc. annual eps for 2024 was $0.40.
EPS
QUARTERLY · USD
RenovoRx Inc. EPS — FAQ
RenovoRx Inc. (RNXT) eps over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is RenovoRx Inc.'s eps?
RenovoRx Inc. (RNXT) reported eps of $-0.32 for fiscal 2025.
Where can I see RNXT's eps history?
The chart and table above show RenovoRx Inc.'s eps by year and by quarter, including the growth rate.